parkinson glutathione oxidative ipsc crispr Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease Frontiers | Mitochondrial Dysfunction in
Frontiers Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024 PMC Frontiers Development of CRISPR Cas9, spin off technologies and their application in model construction and potential therapeutic methods of Parkinson's disease CRISPR And iPSC Disease Modeling And Drug Screening Oxidative stress monitoring in iPSC derived motor neurons using genetically encoded biosensors of H2O2 Scientific Reports
Pay in 4 interest-free payments of $6.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28




